Literature DB >> 23506869

The solute carrier family 10 (SLC10): beyond bile acid transport.

Tatiana Claro da Silva1, James E Polli, Peter W Swaan.   

Abstract

The solute carrier (SLC) family 10 (SLC10) comprises influx transporters of bile acids, steroidal hormones, various drugs, and several other substrates. Because the seminal transporters of this family, namely, sodium/taurocholate cotransporting polypeptide (NTCP; SLC10A1) and the apical sodium-dependent bile acid transporter (ASBT; SLC10A2), were primarily bile acid transporters, the term "sodium bile salt cotransporting family" was used for the SLC10 family. However, this notion became obsolete with the finding of other SLC10 members that do not transport bile acids. For example, the sodium-dependent organic anion transporter (SOAT; SLC10A6) transports primarily sulfated steroids. Moreover, NTCP was shown to also transport steroids and xenobiotics, including HMG-CoA inhibitors (statins). The SLC10 family contains four additional members, namely, P3 (SLC10A3; SLC10A3), P4 (SLC10A4; SLC10A4), P5 (SLC10A5; SLC10A5) and SLC10A7 (SLC10A7), several of which were unknown or considered hypothetical until approximately a decade ago. While their substrate specificity remains undetermined, great progress has been made towards their characterization in recent years. Explicitly, SLC10A4 may participate in vesicular storage or exocytosis of neurotransmitters or mastocyte mediators, whereas SLC10A5 and SLC10A7 may be involved in solute transport and SLC10A3 may have a role as a housekeeping protein. Finally, the newly found role of bile acids in glucose and energy homeostasis, via the TGR5 receptor, sheds new light on the clinical relevance of ASBT and NTCP. The present mini-review provides a brief summary of recent progress on members of the SLC10 family.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23506869      PMCID: PMC3602841          DOI: 10.1016/j.mam.2012.07.004

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  121 in total

1.  Cloning and molecular characterization of the orphan carrier protein Slc10a4: expression in cholinergic neurons of the rat central nervous system.

Authors:  J Geyer; C F Fernandes; B Döring; S Burger; J R Godoy; S Rafalzik; T Hübschle; R Gerstberger; E Petzinger
Journal:  Neuroscience       Date:  2008-02-08       Impact factor: 3.590

2.  Electrostatic and potential cation-pi forces may guide the interaction of extracellular loop III with Na+ and bile acids for human apical Na+-dependent bile acid transporter.

Authors:  Antara Banerjee; Naissan Hussainzada; Akash Khandelwal; Peter W Swaan
Journal:  Biochem J       Date:  2008-03-01       Impact factor: 3.857

3.  Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts.

Authors:  Fadi Annaba; Zaheer Sarwar; Pradeep Kumar; Seema Saksena; Jerrold R Turner; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-12-06       Impact factor: 4.052

4.  Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea.

Authors:  Sara Balesaria; Robert J Pell; Lucy J Abbott; Ali Tasleem; Konstantia-Marie Chavele; Natalie F Barley; Umma Khair; Alex Simon; Kieran J Moriarty; W Gordon Brydon; Julian R F Walters
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-05       Impact factor: 2.566

5.  Genomic analyses identify gene candidates for acquired irinotecan resistance in melanoma cells.

Authors:  Kai Gao; William W Lockwood; Jun Li; Wan Lam; Gang Li
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

6.  Conformational flexibility of helix VI is essential for substrate permeation of the human apical sodium-dependent bile acid transporter.

Authors:  Naissan Hussainzada; Akash Khandewal; Peter W Swaan
Journal:  Mol Pharmacol       Date:  2007-10-30       Impact factor: 4.436

7.  Cytosolic half of transmembrane domain IV of the human bile acid transporter hASBT (SLC10A2) forms part of the substrate translocation pathway.

Authors:  Chandra M Khantwal; Peter W Swaan
Journal:  Biochemistry       Date:  2008-03-01       Impact factor: 3.162

8.  Molecular and phylogenetic characterization of a novel putative membrane transporter (SLC10A7), conserved in vertebrates and bacteria.

Authors:  José R Godoy; Carla Fernandes; Barbara Döring; Knut Beuerlein; Ernst Petzinger; Joachim Geyer
Journal:  Eur J Cell Biol       Date:  2007-07-12       Impact factor: 4.492

9.  The novel putative bile acid transporter SLC10A5 is highly expressed in liver and kidney.

Authors:  Carla F Fernandes; José R Godoy; Barbara Döring; Marcia C O Cavalcanti; Martin Bergmann; Ernst Petzinger; Joachim Geyer
Journal:  Biochem Biophys Res Commun       Date:  2007-07-10       Impact factor: 3.575

10.  Localization of the Sodium-Taurocholate cotransporting polypeptide in membrane rafts and modulation of its activity by cholesterol in vitro.

Authors:  Héctor Molina; Lorena Azocar; Meenakshisundaram Ananthanarayanan; Marco Arrese; Juan Francisco Miquel
Journal:  Biochim Biophys Acta       Date:  2008-02-08
View more
  61 in total

Review 1.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

Review 2.  Structural insights into the transport of small molecules across membranes.

Authors:  Nicholas Noinaj; Susan K Buchanan
Journal:  Curr Opin Struct Biol       Date:  2014-03-28       Impact factor: 6.809

3.  Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Jameson Forster; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2015-05-21       Impact factor: 4.849

Review 4.  Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.

Authors:  Jessica Tsuei; Thinh Chau; David Mills; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

5.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century.

Authors:  Supratim Choudhuri; Geoffrey W Patton; Ronald F Chanderbhan; Antonia Mattia; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2018-01-01       Impact factor: 4.849

7.  Role of Sodium Taurocholate Cotransporting Polypeptide as a New Reporter and Drug-Screening Platform: Implications for Preventing Hepatitis B Virus Infections.

Authors:  Menq-Rong Wu; Yi-You Huang; Jong-Kai Hsiao
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

8.  Genome-wide identification of the BASS gene family in four Gossypium species and functional characterization of GhBASSs against salt stress.

Authors:  Thwin Myo; Fang Wei; Honghao Zhang; Jianfeng Hao; Bin Zhang; Zhixian Liu; Gangqiang Cao; Baoming Tian; Gongyao Shi
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

9.  Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression.

Authors:  Rex A Parker; Ricardo Garcia; Carol S Ryan; Xiaoqin Liu; Petia Shipkova; Valentin Livanov; Pritesh Patel; Siew P Ho
Journal:  J Lipid Res       Date:  2013-04-24       Impact factor: 5.922

Review 10.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.